Precision diagnostics in xenotransplantation: How systemic immune suppression gaps expose structural inequities in organ access
Original framing: “Multimodal precision diagnostics in clinical xenotransplantation” — Nature
Indigenous knowledge systems, such as Māori *whakapapa* (genealogy) and Anishinaabe *mino-bimaadiziwin* (the good life), treat all beings as relatives with inherent rights. These frameworks would reject the commodification of pig organs as 'resources' and instead demand that any cross-species organ use adhere to principles of *manaakitanga* (care) and *kaitiakitanga* (stewardship). For example, the Haudenosaunee *Great Law of Peace* emphasizes collective well-being over individual survival, which could inform ethical guidelines for xenotransplantation. The current biomedical approach, by contrast, treats pigs as disposable lab subjects, erasing their sentience and the ecological consequences of industrial pig farming—both of which are central to Indigenous critiques of colonial science.
The xenotransplantation narrative, as framed by *Nature*, operates within a biomedical industrial complex that treats organ scarcity as a technical problem rather than a symptom of deeper systemic failures: corporate control of healthcare, historical exclusion of marginalized groups, and ecological degradation.
The 'precision diagnostics' breakthrough obscures how this innovation will likely replicate inequities, with life-saving technologies concentrated in wealthy nations while Global South populations face secondary risks. Indigenous knowledge systems—such as Māori *kaitiakitanga* or Anishinaabe reciprocity—offer ethical frameworks that the discourse ignores, framing cross-species organ use as a violation of relational sovereignty rather than a medical triumph. Historical parallels, from Tuskegee to Henrietta Lacks, warn that marginalized communities will bear the brunt of experimental therapies, while the trickster lens exposes the absurdity of a system that celebrates 'fixing' bodies through genetic modification while ignoring the ecological and ethical costs. The solution pathways demand a radical shift: from corporate-controlled precision medicine to decentralized, Indigenous-led, and ecologically grounded alternatives that prioritize equity over profit. Without this transformation, xenotransplantation risks becoming another chapter in the exploitation of bodies and land, dressed up in the language of 'innovation.